KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Current Assets (2016 - 2025)

Exact Sciences (EXAS) has disclosed Current Assets for 16 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • Quarterly Current Assets fell 0.99% to $1.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, down 0.99% year-over-year, with the annual reading at $1.6 billion for FY2025, 0.99% down from the prior year.
  • Current Assets for Q4 2025 was $1.6 billion at Exact Sciences, down from $1.6 billion in the prior quarter.
  • The five-year high for Current Assets was $1.8 billion in Q1 2021, with the low at $982.3 million in Q4 2022.
  • Average Current Assets over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2021.
  • The sharpest move saw Current Assets tumbled 35.13% in 2021, then surged 33.53% in 2024.
  • Over 5 years, Current Assets stood at $1.4 billion in 2021, then crashed by 31.13% to $982.3 million in 2022, then rose by 21.59% to $1.2 billion in 2023, then skyrocketed by 31.57% to $1.6 billion in 2024, then dropped by 0.99% to $1.6 billion in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $1.6 billion, $1.6 billion, and $1.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.